Replacement of human plasma using sterile solution of human plasma proteins excluding blood coagulation factors
US4900720A · kind A · utility
24Cited by
8References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 6, 1987 |
| Grant date | Feb 13, 1990 |
| Priority date | — |
| Expiry date | Apr 6, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/863
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To maintain an almost unchanged plasma-protein profile in a patient subsequent to plasma exchange, the plasma-exchange medium contains the most essential human serum proteins, except for the coagulation factors, at a concentration of 75 g/l.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.